Franklin Resources
ARTV

Franklin Resources’s Artiva Biotherapeutics ARTV Stock Holding History

Franklin Resources’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Buy
1,997,223
+1,476,896
+284% +$13.5M ﹤0.01% 1016
2026
Q1 		$3.35M Hold
520,327
– – ﹤0.01% 1705
2025
Q4 		$2.23M Hold
520,327
– – ﹤0.01% 1730
2025
Q3 		$1.49M Hold
520,327
– – ﹤0.01% 1902
2025
Q2 		$786K Hold
520,327
– – ﹤0.01% 2105
2025
Q1 		$1.56M Buy
520,327
+26
+0% +$140 ﹤0.01% 1789
2024
Q4 		$5.24M Hold
520,301
– – ﹤0.01% 1329
2024
Q3 		$7.44M Buy
+520,301
New +$6.03M ﹤0.01% 1219

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Franklin Resources's ARTV Position: Q2 2026 in Review

Franklin Resources increased its Artiva Biotherapeutics (ARTV) stake by 284% in Q2 2026, buying an estimated $13.5M and bringing the position to 1,997,223 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Franklin Resources first reported a position in ARTV in Q3 2024 and has held it in 8 quarters since. 72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • Franklin Resources held 1,997,223 shares of Artiva Biotherapeutics worth $19.4M as of Q2 2026.
  • Franklin Resources bought 1,476,896 Artiva Biotherapeutics shares in Q2 2026, an estimated $13.5M.
  • Artiva Biotherapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1016 holding.
  • Franklin Resources first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.